| ENSG00000118412.8 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048407379 |
Resistant |
| ENSG00000182873.4 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03067113 |
Resistant |
| ENSG00000204792.2 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03659238 |
Resistant |
| ENSG00000223466.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036994308 |
Resistant |
| ENSG00000223960.2 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041567689 |
Resistant |
| ENSG00000224846.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011804924 |
Resistant |
| ENSG00000225113.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027930286 |
Resistant |
| ENSG00000225361.3 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028350872 |
Resistant |
| ENSG00000226752.3 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023965708 |
Resistant |
| ENSG00000227388.2 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019894584 |
Resistant |
| ENSG00000229915.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038515491 |
Resistant |
| ENSG00000230925.3 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04093217 |
Resistant |
| ENSG00000231193.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017918953 |
Resistant |
| ENSG00000231903.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047373696 |
Resistant |
| ENSG00000233330.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020739775 |
Resistant |
| ENSG00000233937.2 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020407761 |
Resistant |
| ENSG00000234160.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046013195 |
Resistant |
| ENSG00000236051.2 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032623712 |
Resistant |
| ENSG00000237424.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017688513 |
Resistant |
| ENSG00000239407.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020490496 |
Resistant |
| ENSG00000240770.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010184479 |
Resistant |
| ENSG00000241770.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045051206 |
Resistant |
| ENSG00000244380.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012608923 |
Resistant |
| ENSG00000245275.3 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031343888 |
Resistant |
| ENSG00000246331.2 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013546552 |
Resistant |
| ENSG00000246695.3 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044419457 |
Resistant |
| ENSG00000246889.2 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029648116 |
Resistant |
| ENSG00000249084.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010442956 |
Resistant |
| ENSG00000253476.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02230939 |
Resistant |
| ENSG00000253829.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031660953 |
Resistant |
| ENSG00000254315.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001416963 |
Resistant |
| ENSG00000255276.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012827126 |
Resistant |
| ENSG00000255348.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045073371 |
Resistant |
| ENSG00000256576.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044527379 |
Resistant |
| ENSG00000256747.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032405132 |
Resistant |
| ENSG00000257499.2 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030541507 |
Resistant |
| ENSG00000258096.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031042342 |
Resistant |
| ENSG00000258317.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007874186 |
Resistant |
| ENSG00000258334.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025471316 |
Resistant |
| ENSG00000258486.2 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028541618 |
Resistant |
| ENSG00000258646.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045432137 |
Resistant |
| ENSG00000258733.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034300689 |
Resistant |
| ENSG00000259201.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045852864 |
Resistant |
| ENSG00000260439.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016213727 |
Resistant |
| ENSG00000261096.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044991165 |
Resistant |
| ENSG00000261342.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021369736 |
Resistant |
| ENSG00000261799.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045138753 |
Resistant |
| ENSG00000262194.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027453459 |
Resistant |
| ENSG00000263931.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037730857 |
Resistant |
| ENSG00000265478.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024356063 |
Resistant |
| ENSG00000266900.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004516408 |
Resistant |
| ENSG00000266901.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028600972 |
Resistant |
| ENSG00000267249.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022408242 |
Resistant |
| ENSG00000267457.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048493721 |
Resistant |
| ENSG00000267543.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044809953 |
Resistant |
| ENSG00000267759.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004839132 |
Resistant |
| ENSG00000267798.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030875358 |
Resistant |
| ENSG00000268266.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042402452 |
Resistant |
| ENSG00000269191.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015072973 |
Resistant |
| ENSG00000269906.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043142296 |
Resistant |
| ENSG00000269925.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028690652 |
Resistant |
| ENSG00000269997.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027911301 |
Resistant |
| ENSG00000270061.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011252075 |
Resistant |
| ENSG00000270130.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013120916 |
Resistant |
| ENSG00000270143.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040240234 |
Resistant |
| ENSG00000270174.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04482892 |
Resistant |
| ENSG00000271020.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040266384 |
Resistant |
| ENSG00000271204.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029618243 |
Resistant |
| ENSG00000271778.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048771786 |
Resistant |
| ENSG00000271840.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001623435 |
Resistant |
| ENSG00000272308.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044539734 |
Resistant |
| ENSG00000272518.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003449128 |
Resistant |
| ENSG00000272520.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022841969 |
Resistant |
| ENSG00000272644.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018300086 |
Resistant |
| ENSG00000272707.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00939071 |
Resistant |
| ENSG00000272760.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044977442 |
Resistant |
| ENSG00000272761.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013536933 |
Resistant |
| ENSG00000273240.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026556536 |
Resistant |
| ENSG00000273319.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030275165 |
Resistant |
| ENSG00000273443.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031502371 |
Resistant |
| ENSG00000214803.3 |
Erlotinib |
Esophageal cancer |
0.024065824 |
Resistant |
| ENSG00000226465.1 |
Erlotinib |
Esophageal cancer |
0.009278781 |
Resistant |
| ENSG00000214347.5 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.042952941 |
Resistant |
| ENSG00000219665.4 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.032738506 |
Resistant |
| ENSG00000224020.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.001220902 |
Resistant |
| ENSG00000224844.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.01801444 |
Resistant |
| ENSG00000225760.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.034548392 |
Resistant |
| ENSG00000226674.4 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.017986645 |
Resistant |
| ENSG00000226816.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.007847071 |
Resistant |
| ENSG00000228340.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.046741135 |
Resistant |
| ENSG00000228389.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.01728856 |
Resistant |
| ENSG00000228427.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.029453179 |
Resistant |
| ENSG00000228444.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.023285878 |
Resistant |
| ENSG00000229951.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.039596317 |
Resistant |
| ENSG00000230310.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.000312722 |
Resistant |
| ENSG00000230606.6 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.023784352 |
Resistant |
| ENSG00000231595.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.015161554 |
Resistant |
| ENSG00000231628.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.032037292 |
Resistant |
| ENSG00000232300.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.029207297 |
Resistant |
| ENSG00000232931.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.030817577 |
Resistant |
| ENSG00000233844.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.021560852 |
Resistant |
| ENSG00000234432.3 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.035605509 |
Resistant |
| ENSG00000236308.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.009912199 |
Resistant |
| ENSG00000236643.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.004784351 |
Resistant |
| ENSG00000237149.4 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.048014035 |
Resistant |
| ENSG00000240758.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.047146852 |
Resistant |
| ENSG00000241269.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.040623862 |
Resistant |
| ENSG00000241481.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.014189947 |
Resistant |
| ENSG00000245667.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.029927707 |
Resistant |
| ENSG00000248936.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.049865067 |
Resistant |
| ENSG00000250057.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.005817116 |
Resistant |
| ENSG00000251221.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.022122302 |
Resistant |
| ENSG00000254968.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.029247164 |
Resistant |
| ENSG00000258082.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.032140439 |
Resistant |
| ENSG00000258172.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.021668674 |
Resistant |
| ENSG00000258378.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.045349913 |
Resistant |
| ENSG00000260188.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.044063164 |
Resistant |
| ENSG00000260317.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.028469707 |
Resistant |
| ENSG00000260425.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.013956583 |
Resistant |
| ENSG00000260804.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.037799687 |
Resistant |
| ENSG00000260898.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.043879579 |
Resistant |
| ENSG00000261019.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.029092348 |
Resistant |
| ENSG00000261433.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.027701066 |
Resistant |
| ENSG00000261783.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.014339616 |
Resistant |
| ENSG00000262228.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.021955839 |
Resistant |
| ENSG00000264043.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.015932987 |
Resistant |
| ENSG00000264853.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.010182012 |
Resistant |
| ENSG00000266975.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.014345039 |
Resistant |
| ENSG00000267161.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.039974766 |
Resistant |
| ENSG00000267481.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.0155875 |
Resistant |
| ENSG00000267940.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.036095349 |
Resistant |
| ENSG00000268530.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.046316863 |
Resistant |
| ENSG00000269423.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.040855653 |
Resistant |
| ENSG00000269574.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.045192919 |
Resistant |
| ENSG00000269949.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.019074774 |
Resistant |
| ENSG00000270066.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.042340128 |
Resistant |
| ENSG00000270091.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.030559994 |
Resistant |
| ENSG00000270140.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.043908102 |
Resistant |
| ENSG00000270562.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.037035738 |
Resistant |
| ENSG00000271228.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.011996245 |
Resistant |
| ENSG00000271553.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.035080913 |
Resistant |
| ENSG00000271857.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.046217966 |
Resistant |
| ENSG00000272029.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.022594816 |
Resistant |
| ENSG00000272077.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.041454438 |
Resistant |
| ENSG00000272233.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.019760727 |
Resistant |
| ENSG00000272308.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.038049391 |
Resistant |
| ENSG00000272377.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.031761375 |
Resistant |
| ENSG00000272672.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.0116641 |
Resistant |
| ENSG00000272744.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.001772405 |
Resistant |
| ENSG00000272834.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.017503644 |
Resistant |
| ENSG00000272861.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.024150632 |
Resistant |
| ENSG00000272953.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.001751159 |
Resistant |
| ENSG00000272960.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.039931724 |
Resistant |
| ENSG00000273084.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.009514316 |
Resistant |
| ENSG00000273165.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.022989647 |
Resistant |
| ENSG00000273281.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.019002367 |
Resistant |
| ENSG00000273473.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.049043866 |
Resistant |
| ENSG00000273493.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.010923738 |
Resistant |
| ENSG00000224424.7 |
Erlotinib |
Brain lower grade glioma |
0.025687869 |
Resistant |
| ENSG00000225442.2 |
Erlotinib |
Brain lower grade glioma |
0.036829826 |
Resistant |
| ENSG00000226864.1 |
Erlotinib |
Brain lower grade glioma |
0.001575501 |
Resistant |
| ENSG00000227136.2 |
Erlotinib |
Brain lower grade glioma |
0.046162554 |
Resistant |
| ENSG00000232855.2 |
Erlotinib |
Brain lower grade glioma |
0.020888355 |
Resistant |
| ENSG00000234699.1 |
Erlotinib |
Brain lower grade glioma |
0.039960615 |
Resistant |
| ENSG00000236088.5 |
Erlotinib |
Brain lower grade glioma |
0.042496565 |
Resistant |
| ENSG00000240207.2 |
Erlotinib |
Brain lower grade glioma |
0.019541104 |
Resistant |
| ENSG00000247134.2 |
Erlotinib |
Brain lower grade glioma |
0.01599689 |
Resistant |
| ENSG00000248399.1 |
Erlotinib |
Brain lower grade glioma |
0.049651298 |
Resistant |
| ENSG00000253567.1 |
Erlotinib |
Brain lower grade glioma |
0.039338231 |
Resistant |
| ENSG00000253688.1 |
Erlotinib |
Brain lower grade glioma |
0.004488557 |
Resistant |
| ENSG00000254682.1 |
Erlotinib |
Brain lower grade glioma |
0.041402711 |
Resistant |
| ENSG00000266801.1 |
Erlotinib |
Brain lower grade glioma |
0.040320843 |
Resistant |
| ENSG00000267298.1 |
Erlotinib |
Brain lower grade glioma |
0.018785551 |
Resistant |
| ENSG00000236022.2 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015467627 |
Sensitive |
| ENSG00000248936.1 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027098981 |
Sensitive |
| ENSG00000254154.4 |
Erlotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025341282 |
Sensitive |
| ENSG00000214725.3 |
Erlotinib |
Esophageal cancer |
0.029239323 |
Sensitive |
| ENSG00000223478.1 |
Erlotinib |
Esophageal cancer |
0.002378225 |
Sensitive |
| ENSG00000223579.2 |
Erlotinib |
Esophageal cancer |
0.033983794 |
Sensitive |
| ENSG00000223652.2 |
Erlotinib |
Esophageal cancer |
0.049758302 |
Sensitive |
| ENSG00000224074.3 |
Erlotinib |
Esophageal cancer |
0.037823022 |
Sensitive |
| ENSG00000225173.1 |
Erlotinib |
Esophageal cancer |
0.004563201 |
Sensitive |
| ENSG00000225511.2 |
Erlotinib |
Esophageal cancer |
0.046393871 |
Sensitive |
| ENSG00000226044.1 |
Erlotinib |
Esophageal cancer |
0.024530778 |
Sensitive |
| ENSG00000226200.2 |
Erlotinib |
Esophageal cancer |
0.004252888 |
Sensitive |
| ENSG00000226756.1 |
Erlotinib |
Esophageal cancer |
0.032063517 |
Sensitive |
| ENSG00000227083.1 |
Erlotinib |
Esophageal cancer |
0.018105871 |
Sensitive |
| ENSG00000227308.2 |
Erlotinib |
Esophageal cancer |
0.008108739 |
Sensitive |
| ENSG00000228353.1 |
Erlotinib |
Esophageal cancer |
0.044173536 |
Sensitive |
| ENSG00000231401.1 |
Erlotinib |
Esophageal cancer |
0.002076938 |
Sensitive |
| ENSG00000231709.1 |
Erlotinib |
Esophageal cancer |
0.016549284 |
Sensitive |
| ENSG00000232725.1 |
Erlotinib |
Esophageal cancer |
0.04382822 |
Sensitive |
| ENSG00000235142.3 |
Erlotinib |
Esophageal cancer |
0.023706865 |
Sensitive |
| ENSG00000237149.4 |
Erlotinib |
Esophageal cancer |
0.047897774 |
Sensitive |
| ENSG00000237356.1 |
Erlotinib |
Esophageal cancer |
0.015212478 |
Sensitive |
| ENSG00000237438.2 |
Erlotinib |
Esophageal cancer |
0.044373507 |
Sensitive |
| ENSG00000237989.1 |
Erlotinib |
Esophageal cancer |
0.04043718 |
Sensitive |
| ENSG00000239002.2 |
Erlotinib |
Esophageal cancer |
0.03413543 |
Sensitive |
| ENSG00000241211.1 |
Erlotinib |
Esophageal cancer |
0.020284525 |
Sensitive |
| ENSG00000245281.2 |
Erlotinib |
Esophageal cancer |
0.019314901 |
Sensitive |
| ENSG00000248677.1 |
Erlotinib |
Esophageal cancer |
0.029939035 |
Sensitive |
| ENSG00000249084.1 |
Erlotinib |
Esophageal cancer |
0.027162679 |
Sensitive |
| ENSG00000249359.2 |
Erlotinib |
Esophageal cancer |
0.021367097 |
Sensitive |
| ENSG00000251602.2 |
Erlotinib |
Esophageal cancer |
0.000384798 |
Sensitive |
| ENSG00000253563.2 |
Erlotinib |
Esophageal cancer |
0.032718201 |
Sensitive |
| ENSG00000254929.2 |
Erlotinib |
Esophageal cancer |
0.045040758 |
Sensitive |
| ENSG00000256588.1 |
Erlotinib |
Esophageal cancer |
0.038820458 |
Sensitive |
| ENSG00000257167.2 |
Erlotinib |
Esophageal cancer |
0.043522204 |
Sensitive |
| ENSG00000257264.2 |
Erlotinib |
Esophageal cancer |
0.01214462 |
Sensitive |
| ENSG00000257890.1 |
Erlotinib |
Esophageal cancer |
0.02995604 |
Sensitive |
| ENSG00000259579.1 |
Erlotinib |
Esophageal cancer |
0.035206195 |
Sensitive |
| ENSG00000259802.1 |
Erlotinib |
Esophageal cancer |
0.000404145 |
Sensitive |
| ENSG00000260213.1 |
Erlotinib |
Esophageal cancer |
0.044324638 |
Sensitive |
| ENSG00000261126.3 |
Erlotinib |
Esophageal cancer |
0.020537331 |
Sensitive |
| ENSG00000265148.1 |
Erlotinib |
Esophageal cancer |
0.030160684 |
Sensitive |
| ENSG00000265443.1 |
Erlotinib |
Esophageal cancer |
0.021710231 |
Sensitive |
| ENSG00000266411.1 |
Erlotinib |
Esophageal cancer |
0.021032757 |
Sensitive |
| ENSG00000266717.1 |
Erlotinib |
Esophageal cancer |
0.044091034 |
Sensitive |
| ENSG00000267745.1 |
Erlotinib |
Esophageal cancer |
0.02559282 |
Sensitive |
| ENSG00000268366.1 |
Erlotinib |
Esophageal cancer |
0.007101729 |
Sensitive |
| ENSG00000268912.1 |
Erlotinib |
Esophageal cancer |
0.030107039 |
Sensitive |
| ENSG00000269321.1 |
Erlotinib |
Esophageal cancer |
0.02955066 |
Sensitive |
| ENSG00000270159.1 |
Erlotinib |
Esophageal cancer |
0.024137373 |
Sensitive |
| ENSG00000272430.1 |
Erlotinib |
Esophageal cancer |
0.007695858 |
Sensitive |
| ENSG00000273366.1 |
Erlotinib |
Esophageal cancer |
0.034788321 |
Sensitive |
| ENSG00000181798.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.028083292 |
Sensitive |
| ENSG00000225213.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.047497172 |
Sensitive |
| ENSG00000225761.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.007622777 |
Sensitive |
| ENSG00000227083.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.049208898 |
Sensitive |
| ENSG00000231473.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.005010827 |
Sensitive |
| ENSG00000231758.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.043111734 |
Sensitive |
| ENSG00000232406.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.014091045 |
Sensitive |
| ENSG00000232518.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.022148529 |
Sensitive |
| ENSG00000233108.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.023039676 |
Sensitive |
| ENSG00000233627.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.014026432 |
Sensitive |
| ENSG00000233806.3 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.038878401 |
Sensitive |
| ENSG00000234509.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.034104238 |
Sensitive |
| ENSG00000234945.3 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.03346059 |
Sensitive |
| ENSG00000236434.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.014555243 |
Sensitive |
| ENSG00000237424.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.032591607 |
Sensitive |
| ENSG00000237940.3 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.026589053 |
Sensitive |
| ENSG00000239552.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.039562183 |
Sensitive |
| ENSG00000242042.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.047900948 |
Sensitive |
| ENSG00000242086.4 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.049400158 |
Sensitive |
| ENSG00000242553.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.008348835 |
Sensitive |
| ENSG00000242861.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.044921683 |
Sensitive |
| ENSG00000248599.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.020237079 |
Sensitive |
| ENSG00000248773.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.045133641 |
Sensitive |
| ENSG00000248996.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.040622658 |
Sensitive |
| ENSG00000251023.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.031493273 |
Sensitive |
| ENSG00000254295.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.039805765 |
Sensitive |
| ENSG00000255409.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.025509951 |
Sensitive |
| ENSG00000256116.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.016349697 |
Sensitive |
| ENSG00000256940.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.041045634 |
Sensitive |
| ENSG00000257563.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.040537458 |
Sensitive |
| ENSG00000258268.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.046169527 |
Sensitive |
| ENSG00000258317.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.039241835 |
Sensitive |
| ENSG00000259520.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.006855767 |
Sensitive |
| ENSG00000259672.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.010403854 |
Sensitive |
| ENSG00000259974.2 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.032848322 |
Sensitive |
| ENSG00000260261.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.025390404 |
Sensitive |
| ENSG00000260774.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.012117654 |
Sensitive |
| ENSG00000263727.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.003517024 |
Sensitive |
| ENSG00000266456.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.027642787 |
Sensitive |
| ENSG00000267219.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.037328687 |
Sensitive |
| ENSG00000267278.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.035764437 |
Sensitive |
| ENSG00000268316.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.042083707 |
Sensitive |
| ENSG00000271382.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.046007453 |
Sensitive |
| ENSG00000271751.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.019977215 |
Sensitive |
| ENSG00000271803.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.026622972 |
Sensitive |
| ENSG00000272792.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.0441188 |
Sensitive |
| ENSG00000273185.1 |
Erlotinib |
Chronic Lymphocytic Leukemia |
0.013040854 |
Sensitive |
| ENSG00000223799.1 |
Erlotinib |
Brain lower grade glioma |
0.046440542 |
Sensitive |
| ENSG00000224614.1 |
Erlotinib |
Brain lower grade glioma |
0.010197893 |
Sensitive |
| ENSG00000226237.1 |
Erlotinib |
Brain lower grade glioma |
0.031144733 |
Sensitive |
| ENSG00000226386.1 |
Erlotinib |
Brain lower grade glioma |
0.026648046 |
Sensitive |
| ENSG00000227186.1 |
Erlotinib |
Brain lower grade glioma |
0.031548843 |
Sensitive |
| ENSG00000232586.1 |
Erlotinib |
Brain lower grade glioma |
0.040396549 |
Sensitive |
| ENSG00000232814.2 |
Erlotinib |
Brain lower grade glioma |
0.007772094 |
Sensitive |
| ENSG00000234913.1 |
Erlotinib |
Brain lower grade glioma |
0.034450725 |
Sensitive |
| ENSG00000236449.1 |
Erlotinib |
Brain lower grade glioma |
0.044843724 |
Sensitive |
| ENSG00000237781.2 |
Erlotinib |
Brain lower grade glioma |
0.01668134 |
Sensitive |
| ENSG00000249593.2 |
Erlotinib |
Brain lower grade glioma |
0.018638178 |
Sensitive |
| ENSG00000254226.1 |
Erlotinib |
Brain lower grade glioma |
0.043542607 |
Sensitive |
| ENSG00000254694.1 |
Erlotinib |
Brain lower grade glioma |
0.034022861 |
Sensitive |
| ENSG00000255651.2 |
Erlotinib |
Brain lower grade glioma |
0.032970209 |
Sensitive |
| ENSG00000258920.1 |
Erlotinib |
Brain lower grade glioma |
0.047244452 |
Sensitive |
| ENSG00000259515.1 |
Erlotinib |
Brain lower grade glioma |
0.0100454 |
Sensitive |
| ENSG00000260137.1 |
Erlotinib |
Brain lower grade glioma |
0.038679699 |
Sensitive |
| ENSG00000267004.1 |
Erlotinib |
Brain lower grade glioma |
0.022977374 |
Sensitive |
| ENSG00000267042.1 |
Erlotinib |
Brain lower grade glioma |
0.005732513 |
Sensitive |
